Close X
Monday, November 11, 2024
ADVT 
International

Trump mocks Indian-American VP Kamala Harris' accent

Darpan News Desk IANS, 25 Aug, 2023 12:05 PM
  • Trump mocks Indian-American VP Kamala Harris' accent

Washington, Aug 25 (IANS) Taking a jab at Indian-American Vice President Kamala Harris' accent, saying she "speaks in rhyme", former US President Donald Trump said that he does not see her as a presidential candidate for Democrats.

While his Republican rivals engaged in a war of words at the first presidential primary debate in Milwaukee on Wednesday, Trump appeared on former Fox News presenter Tucker Carlson's show where he took digs at President Joe Biden and Harris.

When asked about the chances of Harris becoming the candidate for Democrats in the next Presidential election, Trump said that "this is not a president of the United States future".

“Well, not really... She (Harris) has some bad moments. Her moments are almost as bad as it is. I think his (Biden) is worse, actually. Yeah. She speaks in, in rhyme. And, it's weird., but she has bad moments,” Trump told Carlson.

"Well, the way she talks... the bus will go here and then the bus will go there because that's what buses do. And it's weird. The whole thing is weird. This is not a president of the United States future. And, I think they probably have some kind of a primary and other people will get involved," he said in a pre-recorded interview, which was posted on X just minutes before the Republican primary debate was aired on Thursday evening.

As for Biden, Trump told Carlson that he is “worse mentally than physically".

In the past, Trump's Republican rival Nikki Haley mocked Biden, saying it's unlikely he will "make it until 86 years-old", adding that a vote on on Biden is a vote on Harris.

In an interview with Fox News, the former South Carolina Governor had said that Biden would die within five years of being re-elected, leaving Harris as the commander-in-chief.

Meanwhile, Trump was formally arrested on Thursday on racketeering and conspiracy charges and released on a $200,000 bond.

He is accused of colluding with 18 other defendants to overturn the 2020 election result in Georgia.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK